CMAC Core project: Impurity Rejection

Project: Research

StatusActive
Effective start/end date1/10/1730/09/19

Funding

  • Takeda Pharmaceutical Company Ltd
  • F Hoffmann La Roche Ltd
  • Eli Lilly and Company
  • Pfizer US
  • Astra Zeneca
  • Glaxo Smithkline (UK)
  • Novartis Pharma AG
  • Bayer Healthcare AG
  • Takeda Pharmaceutical Company Ltd
  • F Hoffmann La Roche Ltd
  • Eli Lilly and Company
  • Astra Zeneca
  • Glaxo Smithkline (UK)
  • Novartis Pharma AG
  • Bayer Healthcare AG